Study of electro-gene therapy on diabetic neuropathy

电基因疗法治疗糖尿病神经病变的研究

基本信息

  • 批准号:
    13670679
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

1. Construction of vector which expresses mouse vegfl64 Mouse vegfl64 Cdna which contains singal peptide sequence was synthesized by RT-PCR from mouse muscle total RNA. This DNA fragment was subcloned into Pcaggs vector which has β-actin promoter and strongly expresses in the skeletal muscles. This plasmid (Pcag-Mv3) was transfected in COS7 cells and its expression was confirmed by western blot analysis2. Gene transfer of mouse vegfl64 into skeletal muscles of normal mice and the effect of vegfl64 on perioheral nerves and organs Fifty ug of Pcag-Mv3 was injected into the anterior tibial muscles of C57B1/6 mice followed by electroporation. After 3 and 9 weeks the sciatic nerves were fixed in glutalaldehyde and stained with toluidine blue. The muscles, liver, spleen and kidney were fixed in 4% paraformaldehyde and stained by hematoxylin and eosin. After 3 weeks the sections of the anterior tiblal muscles showed the marked proliferation of capillary and invasion of monocytes suggesting the local synthesis and secretion of vegfl64. In the liver the extension of sinusoids and the proliferation of endothelial cells were observed probably reflecting the circulation of vegfl64 producted in the muscles by veins. There was no reflecting the circulation of vegfl64 produced in the muscles by veins. There was no morphological differences of spleen and kidney between injected and control mice. After 3 and 9 weeks the sclatic nerves were normal. Though the marked elevation of serum VEGF level was reported in patients with POEM syndrome and it is postulated that VEGF may cause neuropathy in this disease, our data suggest that the short-term elevation of blood VEGF level by our method dose not invoive the peripheral nerves.We are trying vegfl64 gene transfer into skeletal muscles of diabetic mice with diabetic neuropathy
1. 以小鼠肌肉总RNA为原料,采用RT-PCR方法合成含有信号肽序列的小鼠vegfl64 Cdna。该DNA片段被亚克隆到具有β-肌动蛋白启动子并在骨骼肌中强烈表达的Pcaggs载体中。该质粒(Pcag-Mv3)转染COS7细胞,并通过western blot分析证实其表达。小鼠vegfl64在正常小鼠骨骼肌中的基因转移及对周围神经和器官的影响将Pcag-Mv3注射50 ug至C57B1/6小鼠胫骨前肌后电穿孔。3周和9周后,将坐骨神经用谷二醛固定,甲苯胺蓝染色。肌肉、肝、脾、肾用4%多聚甲醛固定,苏木精和伊红染色。3周后,胫前肌切片毛细血管增生,单核细胞浸润,提示vegfl64的局部合成和分泌。在肝脏中,观察到窦的扩张和内皮细胞的增殖,可能反映了血管在肌肉中产生的vegfl64的循环。没有反映血管在肌肉中产生的vegfl64的循环。注射组与对照组脾、肾形态无明显差异。3周和9周后巩膜神经恢复正常。虽然有报道称POEM综合征患者血清中VEGF水平显著升高,并推测VEGF可能导致该疾病的神经病变,但我们的数据表明,通过我们的方法短期升高血液中VEGF水平并不会累及周围神经。我们正在尝试将vegfl64基因转移到患有糖尿病神经病变的糖尿病小鼠的骨骼肌中

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tatsufumi Murakami: "Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation"Muscle Nerve. 27. 237-241 (2003)
Tatsufumi Murakami:“通过电穿孔将全长肌营养不良蛋白 cDNA 转移到成年 mdx 小鼠的骨骼肌中”肌肉神经。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Murakami, T. Nishi, E. Kimura, T. Goto, Y. Maeda, Y. Ushio, M. Uchino and Y. Sunada: "Full- length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation"Muscle & Nerve. 27. 237-241 (2003)
T. Murakami、T. Nishi、E. Kimura、T. Goto、Y. Maeda、Y. Ushio、M. Uchino 和 Y. Sunada:“通过电穿孔将全长肌营养不良蛋白 cDNA 转移到成年 mdx 小鼠的骨骼肌中”肌肉
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MURAKAMI Tatsufumi其他文献

MURAKAMI Tatsufumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MURAKAMI Tatsufumi', 18)}}的其他基金

Basic study of neuroregenerative therapy for diabetic polyneuropathy
糖尿病多发性神经病神经再生治疗的基础研究
  • 批准号:
    23591260
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic study for regenerative medicine in muscular dystrophy by myogenic stem cells
肌源性干细胞再生医学治疗肌营养不良症的基础研究
  • 批准号:
    18590961
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of gene therapy on hypoalgesia in sensory neuropathy using neurotrophic factors
神经营养因子对感觉神经病痛觉减退的基因治疗研究
  • 批准号:
    17590906
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Delta原钙黏蛋白(delta-protocadherin)在脊髓发育过程中的表达和功能调控研究
  • 批准号:
    31000475
  • 批准年份:
    2010
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
开发用于个人基因治疗的微流控原代细胞编辑平台(pCEP)
  • 批准号:
    10337068
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
开发用于个人基因治疗的微流控原代细胞编辑平台(pCEP)
  • 批准号:
    9888845
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Gene therapy for GERD-associated esophageal epithelial barrier dysfunction
GERD相关食管上皮屏障功能障碍的基因治疗
  • 批准号:
    10372106
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of a gene therapy approach to treat acute lung injury using a preclinical, large animal model
使用临床前大型动物模型开发治疗急性肺损伤的基因治疗方法
  • 批准号:
    9044084
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
  • 批准号:
    9254540
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
  • 批准号:
    9050669
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
基于低电场的 IL-30 基因递送基因治疗肝损伤
  • 批准号:
    8882981
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
MiniPlasmid vector platform for non-viral gene therapy
用于非病毒基因治疗的 MiniPlasmid 载体平台
  • 批准号:
    8512989
  • 财政年份:
    2013
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting Airway Smooth Muscle for Asthma Gene Therapy
靶向气道平滑肌的哮喘基因治疗
  • 批准号:
    8586551
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting Airway Smooth Muscle for Asthma Gene Therapy
靶向气道平滑肌的哮喘基因治疗
  • 批准号:
    8246904
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了